Lo Francis

Chief People OfficerAdaptive Biotechnologies Corp (ADPT) · full profile →Form 4 · filed Jul 6, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2.2M
Net Open-Market Flow
-$2.2M
Transactions
19
11 non-derivative · 8 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 2, 2026Option exercise(M)13K$7.80$98K250K
Jul 2, 2026Option exercise(M)13K$12.14$153K263K
Jul 2, 2026Option exercise(M)13K$8.46$107K276K
Jul 2, 2026Sell(S)45K$22.59$1.0M231K
Jul 1, 2026Option exercise(M)14K$8.12$114K289K
Jul 1, 2026Sell(S)9K$22.18$194K280K
Jul 1, 2026Sell(S)42K$22.50$951K238K
Jul 1, 2026Option exercise(M)4K$7.80$27K254K
Jul 1, 2026Option exercise(M)3K$12.14$40K258K
Jul 1, 2026Option exercise(M)12K$8.46$103K270K
Jul 1, 2026Option exercise(M)5K$3.99$19K275K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 2, 2026Option exercise(M)13K$059K
Jul 2, 2026Option exercise(M)13K$0156K
Jul 2, 2026Option exercise(M)13K$060K
Jul 1, 2026Option exercise(M)5K$081K
Jul 1, 2026Option exercise(M)4K$072K
Jul 1, 2026Option exercise(M)14K$0127K
Jul 1, 2026Option exercise(M)3K$0169K
Jul 1, 2026Option exercise(M)12K$073K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001780660-26-000017) within minutes of acceptance. Every field above traces to the original document. Verify it directly: